Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1YH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,648
Award facts
- Contract value 100% obligated
- $57,648.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,648.32 delivery order to AmerisourceBergen Drug Corp for supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order was issued under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a substantial prime IDC valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support capabilities.
The delivery order represents a routine pharmaceutical procurement to support defense healthcare operations. Dupixent (dupilumab) is a biologic medication used to treat conditions such as atopic dermatitis and eosinophilic asthma, and this order falls within AmerisourceBergen's extensive portfolio of specialty medications supplied to the Defense Health Agency and other federal healthcare systems. As a child contract to a larger vehicle, this delivery order leverages the established IDC relationship, enabling efficient procurement of critical pharmaceutical commodities without additional competitive solicitation. AmerisourceBergen's position as a pharmaceutical prime vendor reflects its demonstrated capability to fulfill federal medical supply requirements at scale across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FG1YH?
SPE2DR26FG1YH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FG1YH worth?
The government has obligated $57,648 on SPE2DR26FG1YH.
Is contract SPE2DR26FG1YH an order under another contract?
Yes. SPE2DR26FG1YH is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1YH competed?
The extent of competition for SPE2DR26FG1YH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award